Amicus Therapeutics (FOLD) announced Tuesday morning that it plans to submit a new drug application to the FDA for migalastat for Fabry disease in the fourth quarter of 2017 following a series of discussions with and written communication with the FDA.
from RTT - Before the Bell http://ift.tt/2tM83F3
via IFTTT
No comments:
Post a Comment